|
|
|
Volumn 56, Issue 1, 2007, Pages 62-63
|
|
How do we evaluate a marginally low B12 level?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYANOCOBALAMIN;
HOMOCYSTEINE;
METHYLMALONIC ACID;
CYANOCOBALAMIN DEFICIENCY;
DIAGNOSTIC PROCEDURE;
EARLY DIAGNOSIS;
GOLD STANDARD;
HUMAN;
REVIEW;
SYMPTOMATOLOGY;
TREATMENT RESPONSE;
VITAMIN BLOOD LEVEL;
BLOOD;
EVALUATION;
EVIDENCE BASED MEDICINE;
FEMALE;
GENERAL PRACTICE;
HOSPITALIZATION;
MALE;
PROGNOSIS;
RISK FACTOR;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
EVALUATION STUDIES;
EVIDENCE-BASED MEDICINE;
FAMILY PRACTICE;
FEMALE;
HOMOCYSTEINE;
HUMANS;
MALE;
METHYLMALONIC ACID;
PROGNOSIS;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VITAMIN B 12;
VITAMIN B 12 DEFICIENCY;
|
|
EID: 33846461707
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (7)
|
